Levy MF - Search Results

1

Liver transplantation and health-related quality of life: scoring differences between men and women.

Cowling T, Jennings LW, Goldstein RM, Sanchez EQ, Chinnakotla S, Klintmalm GB, Levy MF. Cowling T, et al. Among authors: levy mf. Liver Transpl. 2004 Jan;10(1):88-96. doi: 10.1002/lt.20013. Liver Transpl. 2004. PMID: 14755784 Free article.

2

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects.

Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa TA, Klintmalm G. Bäckman L, et al. Transplantation. 1994 Feb 27;57(4):519-25. Transplantation. 1994. PMID: 7509516

3

Chronic nephrotoxicity of FK 506 after liver transplantation.

Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T, Klintmalm G. Bäckman L, et al. Transplant Proc. 1994 Jun;26(3):1803. Transplant Proc. 1994. PMID: 7518159 No abstract available.

4

Whole blood and plasma levels of FK 506 after liver transplantation: correlation with toxicity.

Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa T, Klintmalm G. Bäckman L, et al. Transplant Proc. 1994 Jun;26(3):1804. Transplant Proc. 1994. PMID: 7518160 No abstract available.

5

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

Abouljoud MS, Levy MF, Klintmalm GB. Abouljoud MS, et al. Among authors: levy mf. Transplant Proc. 1995 Feb;27(1):1121-3. Transplant Proc. 1995. PMID: 7533360 Clinical Trial. No abstract available.

6

Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group.

Bäckman L, Levy MF, Klintmalm G. Bäckman L, et al. Among authors: levy mf. Transplant Proc. 1995 Feb;27(1):1124. Transplant Proc. 1995. PMID: 7533361 Clinical Trial. No abstract available.

7

Outcome analysis of FK 506 therapy for acute and chronic rejection.

Gibbs JF, Husberg BS, Klintmalm GB, Backman L, Levy M, McMillan R, Goldstein RM, Holman MJ, Gonwa TA, Morris C. Gibbs JF, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):622-3. Transplant Proc. 1993. PMID: 7679823 Clinical Trial. No abstract available.

8

Rejection: FK 506 for rescue or maintenance.

Klintmalm GB, Gibbs JF, McMillan R, Backman L, Levy M, Goldstein RM, Husberg BS, Holman MJ, Gonwa TA. Klintmalm GB, et al. Transplant Proc. 1993 Apr;25(2):1914-5. Transplant Proc. 1993. PMID: 7682356 No abstract available.

9

A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation.

Abouljoud MS, Levy MF, Rees CR, Diamond NG, Lee SP, Mulligan DC, Goldstein RM, Husberg B, Gonwa TA, Klintmalm GB. Abouljoud MS, et al. Among authors: levy mf. Transplantation. 1995 Jan 27;59(2):226-9. Transplantation. 1995. PMID: 7839445 Clinical Trial.

10

Impact of pretransplant renal function on survival after liver transplantation.

Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Gonwa TA, et al. Transplantation. 1995 Feb 15;59(3):361-5. Transplantation. 1995. PMID: 7871566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters